CSE: BUX | OTCQB: BMKDF

BioMark™ Diagnostics

New Discovery

BioMark has recently completed a very encouraging metabolome study that has implication for biomarker signature related to cancer diagnosis. The discovery is being patented.

Contact BioMark Diagnostics

Canadian Stock Exchange

CSE: BUX
BioMark Diagnostics Inc.
$0.55
+0.00 (0.00%)
Last updated: Market close • Delayed quote
View Live Quote on Yahoo Finance →

OTC Markets

OTCQB: BMKDF
BioMark Diagnostics Inc.
$0.40
+0.00 (0.00%)
Last updated: Market close • Delayed quote
View Live Quote on Yahoo Finance →

Frankfurt Stock Exchange

FSE: 20B
BioMark Diagnostics Inc.
€0.36
+0.00 (0.00%)
Last updated: Market close • Delayed quote
View Live Quote on Yahoo Finance →

Share This Post

Facebook
X
LinkedIn
Reddit
VK
StumbleUpon
Telegram
XING
WhatsApp
Threads
Email
Print

Related News

Sign up for the latest BioMark news